SciELO - Scientific Electronic Library Online

 
vol.134 número6Hepatitis C en Chile: Magnitud del problema índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

NOGALES-GAETE, Jorge; ARRIAGADA R, Camilo  e  SALINAS R, Rodrigo. Treatment of neurocysticercosis: A review. Rev. méd. Chile [online]. 2006, vol.134, n.6, pp.789-796. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872006000600017.

Neurocysticercosis (NCC) is the most common parasitic disease of the central nervous system. Several drugs, such as drugs against tapeworms, praziquantel or albendazole associated to corticosteroids, have been tested for the treatment of this condition. Although some have claimed the reduction or involution of cystic or granulomatous lesions, there is no consensus about the efficacy of these treatments. The natural evolution of the disease is not clear and this hampers the assessment of treatment effects. Moreover, there are no good imaging or clinical indicators that can predict the progression or spontaneous resolution of lesions, specially at the meningeal or ventricular compartment. Therefore, evidence based medicine does not have a definitive answer about the treatment, neither of seizures, the most common manifestation of NCC, or the varied and complex meningeal and ventricular involvement. This review includes experts opinions to give the clinician some clues for decision making in the treatment of NCC

Palavras-chave : Albendazole; Neurocysticercosis; Praziquantel; Treatment.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons